Latest filing published 05 Aug 2020 for Baxter International INC, €139k.
Filing timeline
BuySaleInsider track record
James R. Gavin III: trading record in brief
James R. Gavin III discloses dealings in 3 companies, chiefly Baxter International Inc, Amylin Pharmaceuticals Inc and Baxalta Inc. Between 9 May 2006 and 3 August 2020, the trades on record add up to 52 filings.
The open-market record consists of 12 sales worth €4.5M, with no purchase. Outside the open market, there are 19 share grants and 15 option exercises. Since January 2020: no purchases and 2 sales on the market.
The record was last updated on 5 August 2020 with an option exercise (€344k) in Baxter International Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to James R. Gavin III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,110 shares@ US$39.838.8% of flowCommon Stock, $1 par valueSEC:0000899243-20-021491:0
- 10,789 shares@ US$37.5021.8% of flowCommon Stock, $1 par valueSEC:0000899243-20-021491:1
- 11,548 shares@ US$86.2653.7% of flowCommon Stock, $1 par valueSEC:0000899243-20-021491:2
- 3,351 shares@ US$86.9115.7% of flowCommon Stock, $1 par valueSEC:0000899243-20-021491:3
- 2,197 shares0Common Stock, $1 par valueSEC:0001220966-20-000001:0
- 4,020 shares@ US$29.524.2% of flowCommon Stock, $1 par valueSEC:0001220966-19-000005:0
- 3,930 shares@ US$36.935.2% of flowCommon Stock, $1 par valueSEC:0001220966-19-000005:1
- 7,950 shares@ US$87.6324.9% of flowCommon Stock, $1 par valueSEC:0001220966-19-000005:2
- 2,412 shares0Common Stock, $1 par valueSEC:0001220966-19-000002:0
- 1,332 shares@ US$69.451.7% of flowCommon Stock, $1 par valueSEC:0001220966-18-000002:0
- 3,760 shares@ US$33.772.3% of flowCommon Stock, $1 par valueSEC:0001220966-18-000001:0
- 5,680 shares@ US$26.772.7% of flowCommon Stock, $1 par valueSEC:0001220966-18-000001:1
- 4,320 shares@ US$24.271.9% of flowCommon Stock, $1 par valueSEC:0001220966-18-000001:2
- 4,990 shares@ US$31.262.8% of flowCommon Stock, $1 par valueSEC:0001220966-18-000001:3
- 17,050 shares@ US$64.5119.5% of flowCommon Stock, $1 par valueSEC:0001220966-18-000001:4
- 1,700 shares@ US$65.062.0% of flowCommon Stock, $1 par valueSEC:0001220966-18-000001:5
- 1,616 sharesCommon Stock, $1 par valueSEC:0001220966-17-000003:0
- 4,280 shares@ US$30.732.7% of flowCommon Stock, $1 par valueSEC:0001220966-17-000002:0
- 4,280 shares@ US$51.724.5% of flowCommon Stock, $1 par valueSEC:0001220966-17-000002:1
- 30,747 sharesCommon Stock, $0.01 par valueSEC:0000899243-16-021949:0
- 4,500 sharesCommon Stock, $0.01 par valueSEC:0000899243-16-019800:0
- 2,590 sharesCommon Stock, $1 par valueSEC:0001220966-16-000008:0
- 5,660 shares@ US$17.9731.0% of flowCommon Stock, par value $0.01SEC:0000899243-16-016687:0
- 5,660 shares@ US$39.9769.0% of flowCommon Stock, par value $0.01SEC:0000899243-16-016687:1
- 5,660 shares@ US$20.962.3% of flowCommon Stock, $1 par valueSEC:0001220966-16-000007:0
25 of 52 declarations
